MedPath

Contrad Swiss SA

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of the Effect of the AI500â„¢ SINGLE-DOSE GEL Medical Device in Patients With Reduced Knee Function

Not Applicable
Completed
Conditions
Pain, Chronic
Knee Pain Swelling
Knee Arthritis
Pain, Acute
Knee Injuries
Knee Osteoarthritis
Interventions
Device: AI 500â„¢ SINGLE-DOSE GEL
First Posted Date
2023-06-02
Last Posted Date
2023-06-02
Lead Sponsor
Contrad Swiss SA
Target Recruit Count
35
Registration Number
NCT05886608
Locations
🇮🇹

Humanitas Research Hospital, Rozzano, Milano, Italy

Evaluation of the "ST500 SINGLE- DOSE GEL" in Patients With Symptomatic Long Head of the Biceps Tendon Injury

Not Applicable
Completed
Conditions
Long Head of Biceps Rupture
Interventions
Device: ST500 SINGLE-DOSE GEL
First Posted Date
2023-03-27
Last Posted Date
2023-03-27
Lead Sponsor
Contrad Swiss SA
Target Recruit Count
35
Registration Number
NCT05785520
Locations
🇮🇹

Ospedale Luini Confalonieri, Luino, Varese, Italy

Investigation on a Topical Cosmetic Pain Lotion (Egyfil) for Stiffness and Pain Relief

Not Applicable
Completed
Conditions
Muscle Rigidity
Pain
Interventions
Other: Egyfil Pain Lotion
First Posted Date
2023-02-03
Last Posted Date
2023-07-20
Lead Sponsor
Contrad Swiss SA
Target Recruit Count
26
Registration Number
NCT05711953
Locations
🇮🇹

Stefano Picotti, Cardano Al Campo, Varese, Italy

Evaluation of the Effect of the "CR500 SINGLE-DOSE GEL" Medical Device in Patients With Knee Osteoarthritis (KOA)

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Interventions
Device: CR 500â„¢ SINGLE-DOSE GEL
First Posted Date
2022-12-22
Last Posted Date
2022-12-22
Lead Sponsor
Contrad Swiss SA
Target Recruit Count
38
Registration Number
NCT05661162
Locations
🇮🇹

Istituto Clinico Mater Domini Casa di Cura Privata - Gruppo Humanitas, Castellanza, Varese, Italy

© Copyright 2025. All Rights Reserved by MedPath